# Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation

> **NCT00645801** · PHASE4 · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 158 (actual)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** lubiprostone (Amitiza)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00645801
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2023-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645801, "Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00645801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*